Comparing two radiation approaches for advanced head and neck cancer
Part of Cancer clinical trials.
This trial compares two types of radiation therapy to relieve symptoms from advanced head and neck cancer that cannot be cured. One is a shorter, more precise treatment (SBRT), and the other is standard radiation. The goal is to see which better improves quality of life and reduces side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a type of head and neck cancer (squamous cell) that started in the mouth, throat, voice box, or sinuses, not the nasopharynx.
- Your doctor has decided that you are not healthy enough for high-dose radiation to cure the cancer.
- You are 18 years or older and have a general health score (ECOG) of 0 to 3, meaning you can be up and about.
- You have not had radiation to the head or neck before (except for skin cancer), and no prior chemotherapy or immunotherapy.
- Your tumor is not in certain high-risk spots like the vocal cords, deep throat, or near the brain, and is not larger than 8 cm.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a specific, shorter type of focused radiation to help relieve symptoms from head and neck squamous cell carcinoma. It compares two radiation timing/planning approaches to see which better improves comfort and quality of life.
This trial tests a precise type of radiation called stereotactic radiosurgery for people with head or neck tumors. It may be an option for those who need radiation or chemoradiation as their main treatment or after surgery.
This trial compares two shortened radiation therapy schedules for patients with advanced head and neck cancer that cannot be cured. The goal is to see which schedule provides better symptom relief and quality of life with fewer side effects.
This study tests giving a short course of targeted radiation (SBRT) along with immunotherapy and a targeted drug before surgery for advanced head and neck cancer. The goal is to see if this combination can shrink the tumor and improve outcomes.
This trial tests a new way of giving radiation therapy, called adaptive radiation boost, for people with head and neck cancer. The goal is to see if this approach can better target the cancer and possibly improve outcomes.
This trial compares two ways of giving radiation therapy for head and neck cancer to see if one works as well as the other while possibly being more convenient. You'll be randomly assigned to get either a shorter course of higher-dose radiation or the standard longer course, and the study will track your quality of life during and after treatment.
Hear when a new Advanced Head and Neck Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.